Hepatocyte-specific Epidermal Growth Factor Receptor Deletion Promotes Fibrosis but has no Effect on Steatosis in Fast-food Diet Model of Metabolic Dysfunction-associated Steatotic Liver Disease.

Autor: Bano S; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Copeland MA; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Stoops JW; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Orr A; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Jain S; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Paranjpe S; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Mooli RGR; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Ramakrishnan SK; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Locker J; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Mars WM; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Michalopoulos GK; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Bhushan B; Department of Pathology and Pittsburgh Liver Research Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: bhb14@pitt.edu.

Publikováno v: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2024; Vol. 18 (4), pp. 101380. Date of Electronic Publication: 2024 Jul 20.

Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Autor: Mooli RGR; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Ramakrishnan SK; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Publikováno v: Frontiers in physiology [Front Physiol] 2022 Jul 04; Vol. 13, pp. 946474. Date of Electronic Publication: 2022 Jul 04 (Print Publication: 2022).

Rebuttal to: Inflammation: The Straw That Broke the NAFLD Liver!

Autor: Mooli RGR; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Ramakrishnan SK; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: ramaks@pitt.edu.

Publikováno v: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2022; Vol. 13 (4), pp. 1275. Date of Electronic Publication: 2022 Jan 25.

Intestinal HIF-2α Regulates GLP-1 Secretion via Lipid Sensing in L-Cells.

Autor: Mooli RGR; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Mukhi D; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Pasupulati AK; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Evers SS; Department of Surgery, Ann Arbor, Michigan., Sipula IJ; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Jurczak M; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Seeley RJ; Department of Surgery, Ann Arbor, Michigan., Shah YM; Department of Molecular and Integrative Physiology, Ann Arbor, Michigan; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Ramakrishnan SK; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: ramaks@pitt.edu.

Publikováno v: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2022; Vol. 13 (4), pp. 1057-1072. Date of Electronic Publication: 2021 Dec 11.

Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.

Autor: Mooli RGR; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Rodriguez J; Department of Molecular and Integrative Physiology, Internal Medicine, University of Michigan, Ann Arbor, Michigan., Takahashi S; Departments of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, District of Columbia; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Solanki S; Department of Molecular and Integrative Physiology, Internal Medicine, University of Michigan, Ann Arbor, Michigan., Gonzalez FJ; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ramakrishnan SK; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Molecular and Integrative Physiology, Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: ramaks@pitt.edu., Shah YM; Department of Molecular and Integrative Physiology, Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: shahy@umich.edu.

Publikováno v: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2021; Vol. 12 (2), pp. 585-597. Date of Electronic Publication: 2021 Mar 30.